Scholars Central

EditorialPublished 31 Jan 2023

Hypoxanthine of Ischemic Brain Edema Modified by Glibenclamide

Authors: Sun Jing

Journal of Experimental Stroke & Translational Medicine

Volume 15 · Issue 1 · Pages 01–03

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The development of malignant brain edema is a leading cause of early clinical deterioration and death after ischemic stroke. Lesional swelling exacerbates tissue injury and portends poor long-term functional outcome after stroke. Malignant brain edema [1], the rapid clinical decline in the first 24–72 h after stroke due to mass-occupying tissue swelling, is a highly morbid sequela of large hemispheric stroke. Limited therapies exist for the treatment of brain edema.

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Experimental Stroke & Translational Medicine
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Sun Jing”